Beeline Medicines News and Activities

Acquisition, funding and merger involving Beeline Medicines.

• Beeline Medicines has just announced a $300 Million fundraising (posted on April 20 2026).

View the org chart displaying its 20 main executives

Most searched biographies at Beeline Medicines

• Saqib Islam, Chief Executive Officer
• Daniel Lynch, Chairman of the Board
• Nicholas Downing, Director

Popular executive movements at Beeline Medicines

• Jennifer Vernazza has joined the company as Director, Medical Operations  (posted on April 20 2026).
• Samantha Sandler has joined the company as Head of Communications and Investor Relations  (posted on April 20 2026).
• James Finchen has joined the company as Senior Vice President, Head of Legal  (posted on April 20 2026).

Click here to view some more movements at Beeline Medicines

Create your alert
to follow the executive moves at Beeline Medicines.

Beeline Medicines has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Beeline Medicines

• Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients
• Home - Beeline Medicines
• Terms of Use - Beeline Medicines

Social media about Beeline Medicines

• Beeline Medicines on Wikipedia, Google News & Yahoo Finance
• Beeline Medicines on LinkedIn, X (Twitter) & YouTube